Prostate cancer metastases to bone: Pathophysiology, pain management, and the promise of targeted therapy
- 30 April 2005
- journal article
- review article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 41 (6), 932-940
- https://doi.org/10.1016/j.ejca.2004.12.026
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Mechanisms of Bone MetastasisNew England Journal of Medicine, 2004
- Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and PainJournal of Clinical Oncology, 2003
- Effect of Endothelin-A Receptor Blockade With Atrasentan on Tumor Progression in Men With Hormone-Refractory Prostate Cancer: A Randomized, Phase II, Placebo-Controlled TrialJournal of Clinical Oncology, 2003
- Effects of the Bisphosphonate Olpadronate in Patients With Carcinoma of the Prostate Metastatic to the SkeletonBone, 1998
- Effect of Matrix Metalloproteinase Inhibitor Batimastat on Breast Cancer Regrowth and Metastasis in Athymic MiceJNCI Journal of the National Cancer Institute, 1995
- Vasculotropin/Vascular Endothelial Growth Factor Induces Differentiation in Cultured OsteoblastsBiochemical and Biophysical Research Communications, 1994
- Metastatic Model for Human Prostate Cancer Using Orthotopic Implantation in Nude MiceJNCI Journal of the National Cancer Institute, 1992
- The effects of the endothelin family peptides on cultured osteoblastic cells from rat calvariaeBiochemical and Biophysical Research Communications, 1990
- Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma with special reference to osteomalaciaCancer, 1983
- THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.The Lancet, 1889